Toronto, Canada’s Bioscrypt, a provider of technologies that help companies control access to their facilities, said it will acquire A4Vision, the Sunnyvale, Calif. provider of 3D facial imaging and recognition technology.

Concurrent with the completion of the merger, institutional investors associated with A4Vision have agreed to invest between US$6 million and US$8 million in newly issued Bioscrypt common shares and warrants to purchase Bioscrypt common shares. Following completion the acquisition and financing, new and existing A4Vision investors, including EuroQube SA, In-Q-Tel, Logitech, Menlo Ventures, Motorola Ventures, NTT Leasing Co. Ltd., TAKO Ventures, and Wedge International, will own, on a fully diluted basis, up to approximately 32% of the pro forma company.

(First posted 1/24)